Discontinuation report SODIUM IODIDE I-131 CAPSULES
Report ID | 92065 |
Drug Identification Number | |
Brand name | SODIUM IODIDE I-131 CAPSULES |
Common or Proper name | SODIUM IODIDE I-131 CAPSULES |
Company Name | MALLINCKRODT RP CANADA INC |
Market Status | |
Active Ingredient(s) | SODIUM IODIDE I-131 |
Strength(s) | 0.75mCi, 2mCi, 3mCi, 4mCi, 5mCi, 6mCi, 7mCi, 8mCi, 10mCi, 12mCi, 15mCi, 17mCi, 20mCi, 50mmCi, 100mCi |
Dosage form(s) | Capsule |
Route of administration | Oral |
Packaging size | All |
ATC code | V09FX |
ATC description | Thyroid |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2019-08-20 |
Remaining supply date | 2019-08-20 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Curium Canada Inc 2572 Daniel-Johnson boulevard, Suite 248, Laval, Québec, H7T-2R3 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2019-08-21 | French | Compare |
v1 | 2019-08-21 | English | Compare |
Showing 1 to 2 of 2